Description
Analysis Note Agglutination activity is expressed in μg/mL and is determined from serial dilutions of a 1 mg/mL solution. This activity is the lowest concentration to agglutinate a 2% suspension of human erythrocytes in phosphate buffered saline, pH 6.8, after 1 hr incubation at 25 °C. 
Biochem/physiol Actions PHA consists of two molecular species, an erythroagglutinin （PHA-E） which has low mitogenic activity and high erythroagglutinin activity, and leucoagglutinin （PHA-L） which has high mitogenic and leucoagglutinating activity, but very low erythroagglutinating activity.1,2
PHA-E is not blood group specific, but agglutination can be inhibited by certain oligosaccharides.3 PHA-P is the protein form of PHA prior to separation and purification of erythroagglutinin and leucoagglutinin.4 PHA-M is the mucoprotein form.4 Conjugates are prepared from the corresponding purified lectins.

Properties
form lyophilized powder
potency <40 μg per mL agglutination activity
composition Protein, 60-80% biuret 
total impurities salt, free
storage temp. 2-8°C

Safety
Safety Statements 22-24/25
RTECS TJ3470000

• D0069纖粘連蛋白/纖連蛋白（人血）/纖鏈蛋白/CIG/Fibronectin
• D0068瓊脂糖凝膠4B蛋白A/Protein A-Sepharose 4B, Fast Flow from
• D0067肌紅蛋白/Myoglobin from equine skeletal muscle
• D0066金屬硫蛋白/Metallothionein/MT
• D0065瓊脂糖蛋白A/Protein A–Agarose
• D0064復(fù)合蛋白保護劑HPD/Protein protectant HPD
• D0063復(fù)合蛋白保護劑DSP50/Protein protectant DSP50
• D0062復(fù)合蛋白保護劑DP7/Protein protectant DP7
• D0061復(fù)合蛋白保護劑DP4/Protein protectant DP4
• D0060蛋白保護劑AEP-HBC/Protein protectant AEP-HBC